Ishares Genomics Immunology And Healthcare Etf ETF Forecast

Sell candidate since Jul 31, 2026

The iShares Genomics Immunology and ETF price fell by -1.31% on the last day (Friday, 31st Jul 2026) from $32.76 to $32.33. During the last trading day the ETF fluctuated 2.28% from a day low at $32.07 to a day high of $32.80. The price has fallen in 6 of the last 10 days and is down by -1.43% for this period. Volume has increased on the last day by 23 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 40 thousand shares were bought and sold for approximately $1.29 million.

The ETF lies in the lower part of a wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $31.47 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the ETF is expected to rise 15.55% during the next 3 months and, with a 90% probability hold a price between $36.36 and $42.20 at the end of this 3-month period.

IDNA Signals & Forecast

There are few to no technical positive signals at the moment. The iShares Genomics Immunology and ETF holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the ETF giving a more negative forecast for the ETF. On further gains, the ETF will meet resistance from the long-term Moving Average at $32.42. On a fall, the ETF will find some support from the short-term average at $32.33. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Thursday, July 02, 2026, and so far it has fallen -7.39%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). iShares Genomics Immunology and gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss for iShares Genomics Immunology and ETF

iShares Genomics Immunology and finds support from accumulated volume at $32.29 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This ETF has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the ETF moved $0.730 between high and low, or 2.28%. For the last week, the ETF has had daily average volatility of 1.91%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (IDNA) For The Upcoming Trading Day Of Monday 3rd

For the upcoming trading day on Monday, 3rd we expect iShares Genomics Immunology and Healthcare ETF to open at $32.40, and during the day (based on 14 day Average True Range), to move between $31.99 and $32.67, which gives a possible trading interval of +/-$0.680 (+/-2.13%) up or down from last closing price. If iShares Genomics Immunology and Healthcare ETF takes out the full calculated possible swing range there will be an estimated 2.13% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $32.29 (0.12%) than the resistance at $32.95 (1.92%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is iShares Genomics Immunology and Healthcare ETF ETF A Buy?

The iShares Genomics Immunology and ETF holds several negative signals and despite the positive trend, we believe iShares Genomics Immunology and will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this ETF. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this ETF since the last evaluation from a Buy to a Sell candidate.

Current score: -4.366 Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on August 3, 2026 - $32.40 ( 0.217%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk